March 27, 2020

Cancer Institute Member Spotlight: Dr. Robert Griffin

Much of Dr. Griffin’s work has involved studying the interactions of normal and tumor microvasculature with tumor cells in the context of blood flow, hypoxia and the tumor microenvironment. Applied studies using various nanomaterials (e.g., nanoliposomes and various nanomedicines) for targeted delivery to the tumor vasculature to improve responses to radiation, thermal treatment, or chemotherapy have been a growing interest over the last 10+ years.